About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Leukemia Clinical Trials in Seattle | 65 Studies

Clinical Trials LeukemiaSeattle

Leukemia Clinical Trials in Seattle

Find 65 clinical trials for leukemia near Seattle, Washington. Connect with research centers in your area.

All Leukemia trials nationwide All trials in Seattle

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 65 trials

CompletedAlemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantRATIONALE: Alemtuzumab and glucocorticoids, such as prednisone or methylprednisolone, may be an effective treatment for acute graft-versus-host disease caused by a donor stem cell…NCT00410657·Seattle, Washington CompletedAmerican Ginseng in Treating Patients With Fatigue Caused by CancerRATIONALE: American ginseng may reduce fatigue in patients with cancer.NCT00719563·Scottsdale, Arizona and 325 others

Leukemia Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerThis clinical trial studies the side effects and best dose of giving fludarabine and total-body irradiation (TBI) together followed by a donor stem cell transplant and…NCT00112593·Seattle, Washington

CompletedCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesThis phase II trial studies how well cyclophosphamide works in preventing chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant in patients with…NCT01427881·Seattle, Washington

CompletedValacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationRATIONALE: Antivirals such as valacyclovir act against viruses and may be effective in preventing cytomegalovirus.NCT00045292·Duarte, California and 5 others

CompletedUmbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic DiseaseThis phase II trial studies how well giving an umbilical cord blood transplant together with cyclophosphamide, fludarabine, and total-body irradiation (TBI) works in treating…NCT00719888·Aurora, Colorado and 2 others

CompletedMyeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesRATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophosphamide, and total-body irradiation before a donor umbilical cord blood stem cell transplant helps stop the…NCT00309842·Minneapolis, Minnesota and 1 other

CompletedFludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerThis clinical trial studies fludarabine phosphate, low-dose total body irradiation, and donor stem cell transplant in treating patients with hematologic malignancies or kidney…NCT00005799·Duarte, California and 6 others

CompletedINCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative DiseaseRATIONALE: INCB18424 (Ruxolitinib) may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.NCT01164163·Birmingham, Alabama and 23 others

CompletedPentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell TransplantThis phase II trial studies pentostatin and donor lymphocyte infusion in preventing graft rejection in patients who have undergone donor stem cell transplant.NCT00096161·Salt Lake City, Utah and 4 others

CompletedOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantRATIONALE: Ondansetron may help lessen or prevent nausea and vomiting in patients undergoing stem cell transplant.NCT00795769·Seattle, Washington

Active not recruitingHLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisThe goal of this clinical trial is to determine the effectiveness of Reduced Dose Post-Transplant Cyclophosphamide (PTCy) in patients with hematologic malignancies after receiving…NCT06001385·Phoenix, Arizona and 31 others

CompletedBeclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or ColonRATIONALE: Beclomethasone may be an effective treatment for graft-versus-host disease.NCT00010283·Seattle, Washington

CompletedDonor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological MalignanciesThis phase II trial studies how well donor atorvastatin treatment works in preventing severe graft-versus-host disease (GVHD) after nonmyeloablative peripheral blood stem cell…NCT01527045·Denver, Colorado and 1 other

CompletedHaploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerThis phase II trial studies how well giving fludarabine phosphate, cyclophosphamide, tacrolimus, mycophenolate mofetil and total-body irradiation together with a donor bone marrow…NCT00049504·Seattle, Washington

CompletedMycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantThis phase I/II trial studies whether stopping cyclosporine before mycophenolate mofetil is better at reducing the risk of life-threatening graft-versus-host disease (GVHD) than…NCT00078858·Stanford, California and 9 others

CompletedTotal-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic CancerThis randomized phase III trial is studying total-body irradiation (TBI) and fludarabine phosphate to see how it works compared with TBI alone followed by donor stem cell…NCT00075478·Medford, Oregon and 9 others

TerminatedObatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaThis phase I trial is studying the side effects and best dose of obatoclax mesylate when given together with vincristine sulfate, doxorubicin hydrochloride, and dexrazoxane…NCT00933985·Birmingham, Alabama and 19 others

CompletedSunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyThis phase I trial studies the side effects and the best dose of sunitinib malate in treating human immunodeficiency virus (HIV)-positive patients with cancer receiving…NCT00890747·Los Angeles, California and 10 others

RecruitingDonor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological MalignanciesThis phase II trial studies how well a donor stem cell transplant, treosulfan, fludarabine, and total-body irradiation work in treating patients with blood cancers (hematological…NCT04195633·Seattle, Washington

PreviousPage 2 of 4Next

Other Conditions in Seattle

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Lymphoma